Improved prostate cancer-specific survival and other disease parameters: impact of prostate-specific antigen testing

This publication has 11 references indexed in Scilit:

• Cancer statistics, 2000
  CA: A Cancer Journal for Clinicians, 2000
• Cancer Surveillance Series: Interpreting Trends in Prostate Cancer Part III: Quantifying the Link Between Population Prostate-Specific Antigen Testing and Recent Declines in Prostate Cancer Mortality
  JNCI Journal of the National Cancer Institute, 1999
• Prostate Cancer Screening in Tyrol, Austria: Experience and Results
  European Urology, 1999
• National trends in the epidemiology of prostate cancer, 1973 to 1994: evidence for the effectiveness of prostate-specific antigen screening
  Urology, 1998
• PSA levels and the rate of positive surgical margins in radical prostatectomy specimens preceded by androgen blockade in clinical B2 (T2bNxMo) prostate cancer
  Urology, 1997
• Improving survival for patients with prostate cancer diagnosed in the prostate-specific antigen era
  Urology, 1996
• Measurement of Prostate-Specific Antigen in Serum as a Screening Test for Prostate Cancer
  New England Journal of Medicine, 1991
• Prostate Cancer Detection in a Clinical Urological Practice by Ultrasonography, Digital Rectal Examination and Prostate Specific Antigen
  Journal of Urology, 1990
• Prostate-Specific Antigen as a Serum Marker for Adenocarcinoma of the Prostate
  New England Journal of Medicine, 1987
• The Effects of Early Treatment, Lead Time and Length Bias on the Mortality Experienced by Cases Detected by Screening
  International Journal of Epidemiology, 1982